A REVIEW OF CYCLO(-RGDFK)

The key goal of this review was to look at the role of glutaminase inhibition as a way to handle adaptive resistance to IR in head and neck most cancers. The mix of glutaminase inhibition with telaglenastat and IR was as compared to the effects of independent cure by itself in clonogenic assays and in two xenograft versions. We initially demonstrat